These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 1431553)
1. Chronic granulomatous disease with partial deficiency of cytochrome b558 and incomplete respiratory burst: variants of the X-linked, cytochrome b558-negative form of the disease. Roos D; de Boer M; Borregard N; Bjerrum OW; Valerius NH; Seger RA; Mühlebach T; Belohradsky BH; Weening RS J Leukoc Biol; 1992 Feb; 51(2):164-71. PubMed ID: 1431553 [TBL] [Abstract][Full Text] [Related]
2. A new X-linked variant of chronic granulomatous disease characterized by the existence of a normal clone of respiratory burst-competent phagocytic cells. Woodman RC; Newburger PE; Anklesaria P; Erickson RW; Rae J; Cohen MS; Curnutte JT Blood; 1995 Jan; 85(1):231-41. PubMed ID: 7803797 [TBL] [Abstract][Full Text] [Related]
3. [Molecular aspects of chronic granulomatous disease. "the NADPH oxidase complex"]. Morel F Bull Acad Natl Med; 2007 Feb; 191(2):377-90; discussion 390-2. PubMed ID: 17969555 [TBL] [Abstract][Full Text] [Related]
5. Point mutations in the beta-subunit of cytochrome b558 leading to X-linked chronic granulomatous disease. Bolscher BG; de Boer M; de Klein A; Weening RS; Roos D Blood; 1991 Jun; 77(11):2482-7. PubMed ID: 1710153 [TBL] [Abstract][Full Text] [Related]
6. Cytochrome b558-negative, autosomal recessive chronic granulomatous disease: two new mutations in the cytochrome b558 light chain of the NADPH oxidase (p22-phox). de Boer M; de Klein A; Hossle JP; Seger R; Corbeel L; Weening RS; Roos D Am J Hum Genet; 1992 Nov; 51(5):1127-35. PubMed ID: 1415254 [TBL] [Abstract][Full Text] [Related]
7. Absence of both the 91kD and 22kD subunits of human neutrophil cytochrome b in two genetic forms of chronic granulomatous disease. Parkos CA; Dinauer MC; Jesaitis AJ; Orkin SH; Curnutte JT Blood; 1989 May; 73(6):1416-20. PubMed ID: 2713485 [TBL] [Abstract][Full Text] [Related]
8. Uncommon missense and splice mutations and resulting biochemical phenotypes in German patients with X-linked chronic granulomatous disease. Roesler J; Heyden S; Burdelski M; Schäfer H; Kreth HW; Lehmann R; Paul D; Marzahn J; Gahr M; Rösen-Wolff A Exp Hematol; 1999 Mar; 27(3):505-11. PubMed ID: 10089913 [TBL] [Abstract][Full Text] [Related]
9. NADPH-binding component of the respiratory burst oxidase system: studies using neutrophil membranes from patients with chronic granulomatous disease lacking the beta-subunit of cytochrome b558. Tsunawaki S; Mizunari H; Namiki H; Kuratsuji T J Exp Med; 1994 Jan; 179(1):291-7. PubMed ID: 8270871 [TBL] [Abstract][Full Text] [Related]
10. Hypoxic induction of gene expression in chronic granulomatous disease-derived B-cell lines: oxygen sensing is independent of the cytochrome b558-containing nicotinamide adenine dinucleotide phosphate oxidase. Wenger RH; Marti HH; Schuerer-Maly CC; Kvietikova I; Bauer C; Gassmann M; Maly FE Blood; 1996 Jan; 87(2):756-61. PubMed ID: 8555500 [TBL] [Abstract][Full Text] [Related]
11. Restitution of superoxide generation in autosomal cytochrome-negative chronic granulomatous disease (A22(0) CGD)-derived B lymphocyte cell lines by transfection with p22phax cDNA. Maly FE; Schuerer-Maly CC; Quilliam L; Cochrane CG; Newburger PE; Curnutte JT; Gifford M; Dinauer MC J Exp Med; 1993 Dec; 178(6):2047-53. PubMed ID: 8245781 [TBL] [Abstract][Full Text] [Related]
12. Cloning of murine gp91phox cDNA and functional expression in a human X-linked chronic granulomatous disease cell line. Björgvinsdóttir H; Zhen L; Dinauer MC Blood; 1996 Mar; 87(5):2005-10. PubMed ID: 8634451 [TBL] [Abstract][Full Text] [Related]
13. A novel mutation at a probable heme-binding ligand in neutrophil cytochrome b558 in atypical X-linked chronic granulomatous disease. Tsuda M; Kaneda M; Sakiyama T; Inana I; Owada M; Kiryu C; Shiraishi T; Kakinuma K Hum Genet; 1998 Oct; 103(4):377-81. PubMed ID: 9856476 [TBL] [Abstract][Full Text] [Related]
14. CD34+ peripheral blood progenitors as a target for genetic correction of the two flavocytochrome b558 defective forms of chronic granulomatous disease. Li F; Linton GF; Sekhsaria S; Whiting-Theobald N; Katkin JP; Gallin JI; Malech HL Blood; 1994 Jul; 84(1):53-8. PubMed ID: 7517218 [TBL] [Abstract][Full Text] [Related]
15. Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity. Woodman RC; Erickson RW; Rae J; Jaffe HS; Curnutte JT Blood; 1992 Mar; 79(6):1558-62. PubMed ID: 1312372 [TBL] [Abstract][Full Text] [Related]
16. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. Clark RA; Malech HL; Gallin JI; Nunoi H; Volpp BD; Pearson DW; Nauseef WM; Curnutte JT N Engl J Med; 1989 Sep; 321(10):647-52. PubMed ID: 2770793 [TBL] [Abstract][Full Text] [Related]
17. Absence of both subunits of cytochrome b558 in the UM384 cell line relative to the inability to generate superoxide anions. Champelovier P; Laporte F; Verhoeven AJ; Hilarius P; de Klein A; Revol C; Seigneurin D; Kolodie L Exp Hematol; 1993 Jul; 21(7):885-92. PubMed ID: 8391470 [TBL] [Abstract][Full Text] [Related]
18. Identification of a thermolabile component of the human neutrophil NADPH oxidase. A model for chronic granulomatous disease caused by deficiency of the p67-phox cytosolic component. Erickson RW; Malawista SE; Garrett MC; Van Blaricom G; Leto TL; Curnutte JT J Clin Invest; 1992 May; 89(5):1587-95. PubMed ID: 1314852 [TBL] [Abstract][Full Text] [Related]
19. Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils. Verhoeven AJ; Bolscher BG; Meerhof LJ; van Zwieten R; Keijer J; Weening RS; Roos D Blood; 1989 May; 73(6):1686-94. PubMed ID: 2469497 [TBL] [Abstract][Full Text] [Related]